Study to Compare Effects Of Isobaric Levobupivacaine and Isobaric Ropivacaine In Labor Analgesia

Study to Compare Effects Of Isobaric Injection Levobupivacaine and Isobaric Injection Ropivacaine In Labor Analgesia - LECRA

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080681

Enrollment

Registered

2025-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery Health Condition 2: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: INJECTION LEVOBUPIVACAINE: INJECTION LEVOBUPIVACAINE 25 mg loading dose and then 10mg per hour till delivery Control Intervention1: INJECTION ROPIVACAINE: INJECTION ROPIVACAINE 37.5 mg

Eligibility

Inclusion criteria

Inclusion criteria: all pregnant females of age 18 years TO 40 years

Exclusion criteria

Exclusion criteria: 1 Uncontrolled diabetes and hypertension. 2 Chronic renal diseases 3 Chronic Anemia 4 I.H.D. or any other cardiac condition. 5 Peripheral vascular disease

Design outcomes

Primary

Measure	Time frame
Maternal blood pressure pain relief preservation of lower limb motor power duration and progress of labor fetal outcome were evaluatedTimepoint: BASELINE, 6 HOURS AND 12 HOURS	—

Secondary

Measure	Time frame
hemodynamic stabilityTimepoint: 12 HOURS AND 24 HOURS AFTER SURGERY	—

Countries

India

Contacts

Public ContactDr Anil Kumar

Government Medical College Jalaun

sunit.sachan@gmail.com9532456809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026